CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,818,000 | -20.2% | 948,389 | -36.2% | 26.68% | +185.5% |
| Q2 2021 | $17,323,000 | -44.3% | 1,486,986 | -41.7% | 9.34% | -18.4% |
| Q1 2021 | $31,098,000 | +29.8% | 2,549,031 | +33.1% | 11.45% | +100.8% |
| Q4 2020 | $23,959,000 | +10.7% | 1,915,219 | +33.2% | 5.70% | -48.0% |
| Q3 2020 | $21,634,000 | +33.7% | 1,437,445 | +117.8% | 10.97% | +4.7% |
| Q2 2020 | $16,176,000 | +39.0% | 659,987 | -19.5% | 10.48% | -16.6% |
| Q1 2020 | $11,636,000 | +157.2% | 820,000 | +187.7% | 12.56% | +416.9% |
| Q4 2019 | $4,524,000 | – | 285,000 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 755,028 | $1,736,564 | 0.43% |
| Monaco Asset Management SAM | 359,739 | $827,400 | 0.24% |
| Slate Path Capital LP | 2,402,455 | $5,525,647 | 0.15% |
| SANDERS MORRIS HARRIS LLC | 346,212 | $713,426 | 0.15% |
| ADVISORY RESEARCH INC | 257,225 | $591,618 | 0.08% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,100,550 | 0.07% |
| Annandale Capital, LLC | 65,000 | $150 | 0.04% |
| Good Life Advisors, LLC | 112,000 | $257,600 | 0.03% |
| CARLSON CAPITAL L P | 135,000 | $310,500 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 57,888 | $133,142 | 0.02% |